Abstract:Atherosclerosis is a chronic inflammatory disease of the arterial wall with hypercholesterolemia and inflammation representing two major pillars in its pathophysiology. A decade ago, studies unraveled how hypercholesterolemia influences inflammation and revealed that lipids orchestrate leukocyte homeostasis. Hypercholesterolemia-associated monocytosis and neutrophilia directly correlate with lesional leukocyte counts and lesion dimension in mice and with the incidence of cardiovascular events in humans.[1] [2] [3] In mice, for example, counts of circulating Ly6C hi inflammatory monocytes correlate with atherosclerotic lesion burden.[2] [4] Similarly, circulating neutrophil counts expand under hypercholesterolemia correlating with atherosclerotic plaque size and lesional neutrophil accumulation.[1] [5] [6] Analogous associations were already found in the 1970s, when it was noticed that peripheral leukocyte counts predict future cardiovascular events.[7] Very recently, these observations were extended by providing proof for the causality between high neutrophil counts and the risk for cardiovascular morbidity across several end points.[8] [9] Formyl-peptide receptor 1 (FPR1) is an ancient receptor for bacterial derived motifs including the needle cap protein of Yersinia pestis [10] as well as of formylated peptides that are released from all bacteria. Yet, given the fact that eukaryote mitochondria are of bacterial origin,[11] it is not surprising that mitochondrial damage in the case of cell necrosis releases host-derived formyl-peptides. Among circulating immune cells, FPR1 is predominantly expressed on neutrophils and hence lack of this receptor impairs neutrophil recruitment in the context of bacterial infections and tissue necrosis.[12] [13] [14] However, the role of FPR1 in vascular inflammation remains thus far unknown. Hence, we crossed FPR1-deficient ( Fpr1 −/− ) and apolipoprotein E-deficient ( Apoe −/− ) animals and fed these mice western diet (WD) or normal chow diet for 4 weeks and performed subsequent flow cytometric and histological sample assessment ([Fig. 1A]). Mice were sacrificed and body weight, plasma cholesterol, and triglyceride levels were determined but remained unaltered between the groups (data not shown). Subsequent analysis of leukocyte counts in blood, however, revealed hypercholesterolemia-associated neutrophilia only in Apoe −/− but not in Apoe −/− Fpr1 −/− animals ([Fig. 1B]). Interestingly, this effect could not be recapitulated in bone marrow or spleen of Apoe −/− Fpr1 −/− mice ([Fig. 1C, D]). The latter indicates a critical role for FPR1 in controlling neutrophil numbers in blood under hyperlipidemic conditions. Given that the frequency of annexin V + neutrophils in blood of FPR1 competent and deficient mice was not different, we concluded that neutrophil apoptosis was likely no contributor to lower neutrophil blood counts in FPR1-deficient mice ([Fig. 1E]). Importantly, the number of colony forming units (CFU) in bone marrow cells increased upon hyperlipidemia but remained unchanged between Apoe −/− and Apoe −/− FPR1 −/− mice ([Fig. 1F]). With apoptosis and production being unaltered, we assumed that possibly the mobilization of neutrophils from the bone marrow is impaired. To test this idea, we performed bromodeoxyuridine (BrdU) pulse labeling and quantified the appearance of BrdU-positive neutrophils in blood over time. In agreement with our hypothesis, neutrophils from FPR1-defcient mice exhibited impaired mobilization capacities ([Fig. 1G]). Preclinical and recent clinical data strongly suggest a correlation between circulating neutrophil counts and cardiovascular disease burden.[1] [8] Here, we analyzed a published human scRNAseq dataset of advanced atherosclerotic lesions (GSE155512,[15]) and an unpublished murine scRNAseq dataset of brachiocephalic arteries from Apoe −/− mice fed with WD for 16 weeks for cell-specific FPR1 expression. In both datasets, FPR1 expression was restricted to myeloid cells and in particular to neutrophils as evident from clustering of CSF1R and S100A8 together with FPR1 ([Fig. 1H] and data not shown). Further, we studied how lack of FPR1 impacts on early atherogenesis and lesion composition. Therefore, we analyzed the number of neutrophils and macrophages in aortic cell suspensions of WD fed Apoe −/− and Apoe −/− Fpr1 −/− mice. H -Abstract Truncated-

Formyl-peptide receptor is not involved in the protection afforded by annexin 1 in murine acute myocardial infarct

Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms

Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26)

Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation

Unleashing the power of formyl peptide receptor 2 in cardiovascular disease

Expression of annexin-1 in equine leucocytes and the effects of the N-terminal annexin-1 peptide, Ac2-26, on equine neutrophil superoxide production

Annexin 1 and melanocortin peptide therapy for protection against ischaemic-reperfusion damage in the heart

Ac2-26, an Annexin A1 Peptide, Attenuates Ischemia-Reperfusion-Induced Acute Lung Injury

Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling

The role and mechanism of the annexin A1 peptide Ac2-26 in rats with cardiopulmonary bypass lung injury

Annexin A1 protects against cerebral ischemia–reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway

Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke

Lack of Formyl-peptide Receptor 1 Mitigates Atherosclerosis in Hyperlipidemic Mice

Annexin A1 N-terminal derived Peptide ac2-26 exerts chemokinetic effects on human neutrophils

Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells

Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury

Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction

Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system

Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro

Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation

Formyl peptide receptors and the regulation of ACTH secretion: targets for annexin A1, lipoxins, and bacterial peptides